advertisement

Topcon

Bacharach J 15

Showing records 1 to 15 | Display all abstracts from Bacharach J

125320 Sepetaprost 0.002% Noninferiority vs. Timolol 0.5% in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: ANGEL-2
Wirta DL
Ophthalmology. Glaucoma 2025; 0:
126658 Negative Pressure Application by the Ocular Pressure Adjusting Pump to Lower Intraocular Pressure in Normal-Tension Glaucoma: HERCULES Study
Ferguson TJ
American Journal of Ophthalmology 2025; 275: 121-134
125399 Effects of Switching to Netarsudil/Latanoprost Fixed Dose Combination from Various Latanoprost Regimens: The Phase 4 MORE Study
Bacharach J
Clinical Ophthalmology 2025; 19: 175-186
126658 Negative Pressure Application by the Ocular Pressure Adjusting Pump to Lower Intraocular Pressure in Normal-Tension Glaucoma: HERCULES Study
Samuelson TW
American Journal of Ophthalmology 2025; 275: 121-134
125399 Effects of Switching to Netarsudil/Latanoprost Fixed Dose Combination from Various Latanoprost Regimens: The Phase 4 MORE Study
Sadri E
Clinical Ophthalmology 2025; 19: 175-186
125320 Sepetaprost 0.002% Noninferiority vs. Timolol 0.5% in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: ANGEL-2
El-Harazi SM
Ophthalmology. Glaucoma 2025; 0:
125399 Effects of Switching to Netarsudil/Latanoprost Fixed Dose Combination from Various Latanoprost Regimens: The Phase 4 MORE Study
Sawhney G
Clinical Ophthalmology 2025; 19: 175-186
125320 Sepetaprost 0.002% Noninferiority vs. Timolol 0.5% in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: ANGEL-2
Tepedino ME
Ophthalmology. Glaucoma 2025; 0:
126658 Negative Pressure Application by the Ocular Pressure Adjusting Pump to Lower Intraocular Pressure in Normal-Tension Glaucoma: HERCULES Study
Herndon L
American Journal of Ophthalmology 2025; 275: 121-134
125320 Sepetaprost 0.002% Noninferiority vs. Timolol 0.5% in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: ANGEL-2
Bacharach J
Ophthalmology. Glaucoma 2025; 0:
126658 Negative Pressure Application by the Ocular Pressure Adjusting Pump to Lower Intraocular Pressure in Normal-Tension Glaucoma: HERCULES Study
Terveen DC
American Journal of Ophthalmology 2025; 275: 121-134
125399 Effects of Switching to Netarsudil/Latanoprost Fixed Dose Combination from Various Latanoprost Regimens: The Phase 4 MORE Study
Kopczynski C
Clinical Ophthalmology 2025; 19: 175-186
126658 Negative Pressure Application by the Ocular Pressure Adjusting Pump to Lower Intraocular Pressure in Normal-Tension Glaucoma: HERCULES Study
Bacharach J
American Journal of Ophthalmology 2025; 275: 121-134
125399 Effects of Switching to Netarsudil/Latanoprost Fixed Dose Combination from Various Latanoprost Regimens: The Phase 4 MORE Study
Merchea MM
Clinical Ophthalmology 2025; 19: 175-186
126658 Negative Pressure Application by the Ocular Pressure Adjusting Pump to Lower Intraocular Pressure in Normal-Tension Glaucoma: HERCULES Study
Brubaker JW; Berdahl JP; Radcliffe NM
American Journal of Ophthalmology 2025; 275: 121-134

Issue 25-2

Change Issue


advertisement

WGA Rescources